Himfr Reports Ceftriaxone production exports grew prices high

Read More About Business

According to industry associations to conservative statistics, ceftriaxone in 2009 full year production reached 3,768 tons, an increase of 29%, exports grew by 36.66%. In the production and export all the way up under the beginning of this year ceftriaxone has climbed to price new heights, and reach in 2008 the highest level since. Into March, the price of running remained steady.

As the clinical dosage was increased, ceftriaxone production in higher export volumes also expanded. The current international trade protectionism on the rise, our pharmaceutical products often subject to antidumping proceedings, ceftriaxone is the "victim" one. To this end, domestic manufacturers have also increased to develop new export markets efforts.
Annual growth rate of 106%, the production company more than 40

Since 2000, rapid domestic hospitals promotion has been made ceftriaxone in a large number of accounts for the past, cefazolin, cephradine and other cephalosporins class old drug market share. According to statistics, cefazolin in 1999 once the gross domestic cephalosporins market, 81% of plunging to 2004 national cephalosporin market, 41%; At the same time, ceftriaxone from 1999, only domestic cephalosporin market 2.36 percent increase to account for in 2004 the domestic market of 32.5%, in 2009 this proportion had increased to 43%.

According to Chinese Business Association's statistics, over the past few years, in our country ceftriaxone, cefazolin, cefotaxime, cefoperazone, cefuroxime and ceftazidime in the six largest output of cephalosporins, only ceftriaxone annual growth rate of 106%, the highest cephalosporin growth rate of the first.
The earliest access to ceftriaxone raw material drug production approval of enterprises Northeast Pharmaceutical Factory, Beijing Zizhu Pharmaceutical and Southwest Synthetic Pharmaceutical Factory 3. However, as of 2009, domestic production of ceftriaxone API manufacturers has increased to more than 40. Which yield larger enterprises Hill Xi Weiqi Yongda, Fuzhou Antibiotic Medicine, Yuekang Medicine, Shanghai Pioneer Pharmaceutical, Livzon Pharmaceutical shares, Zhuhai Yue state pharmaceutical, Qi Luan for pharmacy 10, the output together account for about domestic ceftriaxone total about 80%.

Anti-dumping lawsuit distress, uncertainty factors have increased

And other cephalosporin bulk drugs mainly used for domestic sale is different, our country ceftriaxone exports considerably. Over the past few years domestic ceftriaxone API exports has been the country's total output of 3 to 4 percent. In 2008, China's exports ceftriaxone API about 900 tons, of which only India's exports of ceftriaxone meal number is 400 tons, accounting for China's exports of ceftriaxone APIs half.

China ceftriaxone main export market for India, Korea, Europe, Latin America and Southeast Asia. Notably, the European as production costs high and the market volume reduction and other factors, has been very little production ceftriaxone and other cephalosporins, change of imports from China, so China in recent years, Europe ceftriaxone export volume increased year by year. Even Italy and Spain, and other traditional cephalosporin production of power, began importing country ceftriaxone bulk drugs used for the production preparation.
And because ceftriaxone export market promising high profits, which in turn stimulate the country ceftriaxone API production capacity of further expansion. However, the domestic market, the actual capacity can not digest at a faster rate of increase of production, ultimately leading to ceftriaxone meal in bulk export flocked India, Europe and other markets, real-time lead many countries to China ceftriaxone initiated anti-dumping lawsuits.

Government of India Commerce and Industry in October 2008 officially ruled China Export ceftriaxone meal of dumping, and China's four major ceftriaxone producers and exporters are subject to 108% ~ 120% of the anti-dumping duties. This is actually wishing to China's export of ceftriaxone products expelled from the Indian market, because such a high anti-dumping duty of all companies can not afford, only out of the market.

Another source said, including Italy and Spain and other EU countries, including also investigating the Chinese ceftriaxone API dumping, but has not yet been formally proposed anti-dumping charges. As India and Europe are our main ceftriaxone API export markets, these countries the Government of China ceftriaxone dumping allegations will ultimately make the exports face uncertain prospects.

Article Source: http://depositarticles.com/

I am a professional editor from China Products, and my work is to promote a free online trade platform. www.himfr.com/ contain a great deal of information about high purity graphite,high voltage ceramic capacitors,high visibility parka, welcome to visit!

Please Rate this Article

Not yet Rated

Click the XML Icon Above to Receive Business Articles Via RSS!

Additional Articles From - Home | Business

Our other websites
All about SEO
Beauty Tips Forum

	Print This Article
	Post Comment
	Add To Favorites
	Email to Friends
	Ezine Ready

Submit Articles
Member Login
Link Us
Submission Guidelines
Ezine Notifications
Article RSS Feeds
Sitemap

New Stuff
About Us
Developer
Good shopping portal
Link to Us
Contact Us
Privacy Policy
Terms of Service